Matthew Scalo

Matthew Scalo

Investor Relations Contact at MYRIAD GENETICS, INC.
Finance
Health Technology
Consumer Services

Profile

Matthew Scalo is Senior Vice President-Investor Relations at Myriad Genetics, Inc. since 2022.
Former roles include Senior Director-Investor Relations at Luminex Corp., Investor Relations Contact at NextGen Healthcare, Inc., Senior Research Analyst at Allspring Global Investments LLC, Research Analyst at Canaccord Adams, Inc. from 2004 to 2010, VP, Investor Relations & Corporate Development at Cutera, Inc., Associate at Broadpoint.
Gleacher Securities in 2003, and Research Analyst at Canaccord Genuity, Inc. in 2010.
Education includes an MBA from the University of Notre Dame and an undergraduate degree from the University of California, Davis.

Matthew Scalo active positions

CompaniesPositionStart
MYRIAD GENETICS, INC. Investor Relations Contact 01/08/2022

Former positions of Matthew Scalo

CompaniesPositionEnd
Analyst-Equity 31/12/2010
Analyst-Equity 22/04/2010
Analyst-Equity 31/12/2003
Analyst-Equity 31/12/2002
NEXTGEN HEALTHCARE, INC. Investor Relations Contact -
See the detail of Matthew Scalo's experience

Training of Matthew Scalo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Technology Services

Health Technology

Finance

Health Technology

Finance

Health Technology

Consumer Services

Finance

Consumer Services

Finance